Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$81.86
+3.77%
Mkt Cap $3.19B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (17 analysts)
$109.56
Range $55.00 – $145.00
Implied Upside
+33.8%
Consensus $109.56 vs current $81.86
NASDAQ·Healthcare·Biotechnology
$81.86
+3.77%
Mkt Cap $3.19B
Buy
13
Hold
0
Sell
0
Price Target (17 analysts)
$109.56
Range $55.00 – $145.00
+33.8%
Consensus $109.56 vs current $81.86